An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences:: application to the C57BL10J and Alpk:ApfCD mouse

被引:279
作者
Gavaghan, CL
Holmes, E
Lenz, E
Wilson, ID
Nicholson, JK
机构
[1] Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England
[2] AstraZeneca, Drug Metab & Pharmokinet, Macclesfield SKN 4TG, Cheshire, England
关键词
metabonomics; H-1 NMR spectroscopy; metabolite variation; physiological function; metabotype; phenotype;
D O I
10.1016/S0014-5793(00)02147-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As the human genome sequencing projects near completion, there is an active search for technologies that can provide insights into the genetic basis for physiological variation and interpreting gene expression in terms of phenotype at the whole organism level in order to understand the pathophysiology of disease. We present a novel metabonomic approach to the investigation of genetic influences on metabolic balance and metabolite excretion patterns in two phenotypically normal mouse models (C57BL10J and Alpk:ApfCD). Chemometric techniques were applied to optimise recovery of biochemical information from complex H-1 NMR urine spectra and to determine metabolic biomarker differences between the two strains. Differences were observed in tricarboxylic acid cycle intermediates and methylamine pathway activity. We suggest here a new 'metabotype' concept, which will be of value in relating quantitative physiological and biochemical data to both phenotypic and genetic variation in animals and man, (C) 2000 Federation of European Biochemical Societies. Published by Elsevier Science B,V, All rights reserved.
引用
收藏
页码:169 / 174
页数:6
相关论文
共 27 条
[1]   Simultaneous measurement of hundreds of liver proteins: Application in assessment of liver function [J].
Anderson, NL ;
Taylor, J ;
Hofmann, JP ;
EsquerBlasco, R ;
Swift, S ;
Anderson, NG .
TOXICOLOGIC PATHOLOGY, 1996, 24 (01) :72-76
[2]   CLASSIFICATION OF TOXIN-INDUCED CHANGES IN H-1-NMR SPECTRA OF URINE USING AN ARTIFICIAL NEURAL-NETWORK [J].
ANTHONY, ML ;
ROSE, VS ;
NICHOLSON, JK ;
LINDON, JC .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (03) :205-211
[3]   ORIGIN OF URINARY DIMETHYLAMINE [J].
ASATOOR, AM ;
SIMENHOF.ML .
BIOCHIMICA ET BIOPHYSICA ACTA, 1965, 111 (02) :384-&
[4]  
BAKER JR, 1962, J BIOL CHEM, V237, P1309
[5]   Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins [J].
Beckwith-Hall, BM ;
Nicholson, JK ;
Nicholls, AW ;
Foxall, PJD ;
Lindon, JC ;
Connor, SC ;
Abdi, M ;
Connelly, J ;
Holmes, E .
CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (04) :260-272
[6]  
Beebe K.R., 1998, CHEMOMETRICS PRACTIC
[7]  
Gartland K P, 1990, NMR Biomed, V3, P166, DOI 10.1002/nbm.1940030404
[8]  
GULLANS SR, 1989, RENAL PHYSIOL BIOCH, V12, P191
[9]   750 MHz H-1 NMR spectroscopy characterisation of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutaric aciduria and maple syrup urine disease [J].
Holmes, E ;
Foxall, PJD ;
Spraul, M ;
Farrant, RD ;
Nicholson, JK ;
Lindon, JC .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1997, 15 (11) :1647-1659
[10]  
HOLMES E, 1992, MOL PHARMACOL, V42, P922